Cargando…
The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China
PURPOSE: To develop a satisfaction scale of Chinese clinicians with Clinical Pathway (CP) implementation and evaluate its validity, reliability and item discrimination. MATERIALS AND METHODS: Literature review, in-person interviews, and Delphi were used to design the scale. Data were collected in tw...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847415/ https://www.ncbi.nlm.nih.gov/pubmed/33531848 http://dx.doi.org/10.2147/RMHP.S290565 |
_version_ | 1783644929683095552 |
---|---|
author | Li, Junlong Shen, Kui Hu, Jun Li, Xinyue Liu, Jie Du, Yonghong Huang, Kang |
author_facet | Li, Junlong Shen, Kui Hu, Jun Li, Xinyue Liu, Jie Du, Yonghong Huang, Kang |
author_sort | Li, Junlong |
collection | PubMed |
description | PURPOSE: To develop a satisfaction scale of Chinese clinicians with Clinical Pathway (CP) implementation and evaluate its validity, reliability and item discrimination. MATERIALS AND METHODS: Literature review, in-person interviews, and Delphi were used to design the scale. Data were collected in two phases using random sampling on the spot and an online survey. In the first phase, data from 239 clinicians were investigated in exploratory factor analysis. In the second phase, 513 valid questionnaires were collected and used for confirmatory factor analysis. RESULTS: The scale developed in this study has three dimensions (organization support, process identity, and effect perception) and a total of 21 items. Cronbach’s alpha of each dimension was higher than 0.9. The 3-factor model had enough fitness (χ2/df = 5.602, NFI = 0.926, IFI = 0.938, CFI = 0.938, RFI = 0.914, TLI = 0.929, RMSEA = 0.095, RMR = 0.045). The standardized factor loadings of 21 variables were between 0.742 and 0.949. The average variance extracted (AVE) of each dimension was higher than 0.7, and the construct reliability (CR) of the dimensions was higher than 0.9. The Chi-square difference test results showed that the difference value between the unlimited and limited model of each two potential constructs was higher than 3.84 (P < 0.001). CONCLUSION: The clinicians’ satisfaction scale developed in this study has good construct validity, convergent validity, discriminant validity, internal consistency, and item discrimination. This suggests its usefulness as a tool to assess the satisfaction of clinicians in the implementation of CP in China. |
format | Online Article Text |
id | pubmed-7847415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78474152021-02-01 The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China Li, Junlong Shen, Kui Hu, Jun Li, Xinyue Liu, Jie Du, Yonghong Huang, Kang Risk Manag Healthc Policy Original Research PURPOSE: To develop a satisfaction scale of Chinese clinicians with Clinical Pathway (CP) implementation and evaluate its validity, reliability and item discrimination. MATERIALS AND METHODS: Literature review, in-person interviews, and Delphi were used to design the scale. Data were collected in two phases using random sampling on the spot and an online survey. In the first phase, data from 239 clinicians were investigated in exploratory factor analysis. In the second phase, 513 valid questionnaires were collected and used for confirmatory factor analysis. RESULTS: The scale developed in this study has three dimensions (organization support, process identity, and effect perception) and a total of 21 items. Cronbach’s alpha of each dimension was higher than 0.9. The 3-factor model had enough fitness (χ2/df = 5.602, NFI = 0.926, IFI = 0.938, CFI = 0.938, RFI = 0.914, TLI = 0.929, RMSEA = 0.095, RMR = 0.045). The standardized factor loadings of 21 variables were between 0.742 and 0.949. The average variance extracted (AVE) of each dimension was higher than 0.7, and the construct reliability (CR) of the dimensions was higher than 0.9. The Chi-square difference test results showed that the difference value between the unlimited and limited model of each two potential constructs was higher than 3.84 (P < 0.001). CONCLUSION: The clinicians’ satisfaction scale developed in this study has good construct validity, convergent validity, discriminant validity, internal consistency, and item discrimination. This suggests its usefulness as a tool to assess the satisfaction of clinicians in the implementation of CP in China. Dove 2021-01-26 /pmc/articles/PMC7847415/ /pubmed/33531848 http://dx.doi.org/10.2147/RMHP.S290565 Text en © 2021 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Junlong Shen, Kui Hu, Jun Li, Xinyue Liu, Jie Du, Yonghong Huang, Kang The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China |
title | The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China |
title_full | The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China |
title_fullStr | The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China |
title_full_unstemmed | The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China |
title_short | The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China |
title_sort | clinicians’ satisfaction with clinical pathway implementation: preliminary development of an assessment scale in china |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847415/ https://www.ncbi.nlm.nih.gov/pubmed/33531848 http://dx.doi.org/10.2147/RMHP.S290565 |
work_keys_str_mv | AT lijunlong theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT shenkui theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT hujun theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT lixinyue theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT liujie theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT duyonghong theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT huangkang theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT lijunlong clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT shenkui clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT hujun clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT lixinyue clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT liujie clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT duyonghong clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina AT huangkang clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina |